The Journal of Thoracic and Cardiovascular Surgery
Volume 123, Issue 3 , Pages 406-408 , March 2002

QALYs or quackery? The quagmire of quantifying the cost of breathing

Received 14 September 2001 ,Accepted 27 September 2001.

References 

  1. Williams A. The role of health economics in clinical decision-making: is it ethical?. Respir Med. 1991;85(Suppl B):3–5
  2. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg. 2002;123:411–420
  3. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax. 2001;56:218–222
  4. Burker EJ, Carels RA, Thompson LF, Rodgers L, Egan T. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr Pulmonol. 2000;30:453–460
  5. Brown GC, Sharma S, Brown MM, Garrett S. Evidence-based medicine and cost-effectiveness. J Health Care Finance. 1999;26:14–23
  6. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ. 1999;8:25–39
  7. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 1998;351:24–27
  8. Robinson R. Cost-utility analysis. BMJ. 1993;307:859–862
  9. Petrou S, Renton A. The QALY: a guide for the public health physician. Public Health. 1993;107:327–336
  10. Fryback DG, Lawrence WF. Dollars may not buy as many QALYs as we think: a problem with definig quality-of-life adjustments. Med Decis Making. 1997;17:276–284
  11. Nord E. The relevance of health state after treatment in prioritising between different patients. J Med Ethics. 1993;19:37–42
  12. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. University of Washington Medical Center Lung Transplant Study Group Chest. 1995;108:1594–1601
  13. van Enckovert PJ, TenVergert EM, Bonsel GJ, Geertsma A, van-der BW, de BW, et al.  Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care. 1998;14:344–356
  14. Hadorn DC. Setting health care priorities in Oregon: cost effectivness meets the rule of rescue. JAMA. 1991;265:2218–2225
  15. Jonsen AR. Bentham in a box—technology assessment and health care allocation. Law Med Health Care. 1986;14:172–174
  16. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20:332–342
  17. Orenstein DM, Kaplan RM. Measuring the quality of well-being in cystic fibrosis and lung transplantation: the importance of the area under the curve. Chest.

 Address for reprints: Thomas M. Egan, MD, MSc, Department of Surgery, University of North Carolina at Chapel Hill, 108 Burnett-Womack Building, CB 7065, Chapel Hill, NC 27599-7065.

PII: S0022-5223(02)87850-3

doi: 10.1067/mtc.2002.121526

The Journal of Thoracic and Cardiovascular Surgery
Volume 123, Issue 3 , Pages 406-408 , March 2002